HDT Bio receives Emergency Use Approval for Covid-19 vaccine in India
Gemcovac became the first saRNA vaccine to obtain approval for use in humans in India.

Gemcovac became the first saRNA vaccine to obtain approval for use in humans in India.
Corbevax will be given after six months of the first two doses of either Covaxin or Covishield vaccines.
In December last year, the DCGI approved the vaccine for emergency use in children of the age 12 to 18…
Bharat Biotech is temporarily pausing vaccine production across its manufacturing sites to carry out upgrades.
In December last year, Covovax obtained EUA from DCGI for use in adults aged 18 years and older.
The DCGI approved the vaccine for restricted use in an emergency situation for adults in December last year.
The drug regulator granted approval to CORBEVAX in December last year for restricted use for emergency situations in adults.
Funds of up to $12.5m will be offered to develop multi-epitope, nanoparticle-based vaccine candidates.
Thank you for subscribing to Pharmaceutical Technology